Want to join the conversation?
Clinical diagnostic kits maker $VIVO said it has received clearance from FDA for new illumigene Pertussis molecular amplification test claims, which reduces the effect of inhibitors in biologic samples. This test expands Company's customer base by including specimens collected by ESwab, a liquid-based collection and transport system.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.